The Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome With Dialysis Duration

Basit Öğe Kaydı
dc.contributor.authorKayabasi, Hasan
dc.contributor.authorYilmaz, Zulfukar
dc.contributor.authorYildirim, Idris
dc.contributor.authorYildirim, Yasar
dc.contributor.authorKadiroglu, Ali Kemal
dc.contributor.authorYilmaz, M. Emin
dc.date.accessioned2024-04-24T17:27:33Z
dc.date.available2024-04-24T17:27:33Z
dc.date.issued2011
dc.departmentDicle Üniversitesien_US
dc.description.abstractOBJECTIVE: To evaluate the characteristics of patients with metabolic syndrome, and the association of developing MS with peritoneal dialysis duration among patients undergoing continuous ambulatory peritoneal dialysis. MATERIAL and METHODS: Fifty-eight nondiabetic CAPD patients were evaluated. Biochemical parameters, blood pressure, length, weight, waist circumference, and body mass indexes were recorded. MS was determined using NCP-ATP III criteria. The patients were divided into 3 groups according to dialysis duration (Group 1: <= 60 months, Group 2: 61-120 months, Group 3: >= 121 months) and the frequency of MS was compared. RESULTS: Twenty-four of 58 patients were male, and MS was present in 22 (37.9%) patients. 14 (82.4%) of 22 patients with MS were female, (p=0.544). There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p<0.05). 55% (n=32) of the patients were in group 1, 34.5% (n=20) in group 2, and 10.5% (n=6) in group 3 (p=0.092). The frequency of MS decreased with prolongation of dialysis duration (50% in group 1, 20% in group 2, and 33,3% in group 3) (p<0.001). CONCLUSION: The frequency of MS among our CAPD patients was 37.9% and it decreased with prolongation of dialysis duration. This result may suggest that alterations in metabolic state, and abandoning glucose-based PD solutions may improve MS criteria.en_US
dc.identifier.doi10.5262/tndt.2011.1002.09
dc.identifier.endpage172en_US
dc.identifier.issn1300-7718
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84857875794
dc.identifier.scopusqualityN/A
dc.identifier.startpage168en_US
dc.identifier.urihttps://doi.org/10.5262/tndt.2011.1002.09
dc.identifier.urihttps://hdl.handle.net/11468/20048
dc.identifier.volume20en_US
dc.identifier.wosWOS:000217174400009
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.publisherTurk Nefroloji Diyaliz Transplantasyon Dergisien_US
dc.relation.ispartofTurkish Nephrology Dialysis and Transplantation Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectPeritoneal Dialysisen_US
dc.subjectMetabolismen_US
dc.subjectCardiovascular Risken_US
dc.titleThe Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome With Dialysis Durationen_US
dc.titleThe Frequency Of Metabolic Syndrome in Patients on Continuous Ambulatory Peritoneal Dialysis and the Association of Developing Metabolic Syndrome With Dialysis Duration
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu